僅用于工業應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用. Opicinumab （BIIB033） is a monoclonal antibody against LINGO-1 and has potential application in acute optic neuritis and relapse multiple sclerosis sarcopenia, including wasting atrophy, chronic diseases, and changes in food and nutritional intake